Success Stories: Research Instructor in the Field of Pharmaceutical Sciences in Colorado Received an EB-1A Approval

Client’s Testimonial:

Thank you again for your help. I have already recommend couple of my friends.

We Received an EB-1A Approval on July 27^th, 2014 for aResearch Instructorin the Field of Medicinal Chemistry (Approval Notice)

General Field: Pharmaceutical Sciences

Position at the Time of Case Filing: Research Instructor

Country of Origin: India

Service Center: Nebraska Service Center (NSC)

State of Residence at the Time of Filing: Colorado

Approval Notice Date: July 27, 2014

Processing Time: 6 months and 4 days

Case Summary:

For this EB-1A case, we had the privilege of working with a Research Instructor, who has made substantial contributions and garnered international acclaim in the field of Pharmaceutical Sciences. In his research endeavors, our client has specialized in drug discovery, drug delivery, and biopharmaceutics. He has marked his career with the discovery of ovel antibiotics that are capable of treating drug resistant bacterial infections and the delivery of drugs to the eye with greater bioavailability. The originality of our client’s work has culminated in the authorship of 8 peer-reviewed scientific manuscripts that were published in the top journals of his field and an issued patent. At the time of filing his case, his publications had been cited 81 times by researchers worldwide, demonstrating the global scientific community’s heavy reliance upon his work. Furthermore, his work has been presented and discussed at internationally renowned conferences. The major significance of his work was endorsed by an independent recommender, who stated, “These advances in prodrugs that [Client] pioneered have a profound effect on the pharmaceutical industry, both in US concerns and abroad. Treatment of the posterior eye diseases have been hobbled by the ocular barriers that they have reduced the efficacy of topical drugs. The only way to handle this previously is through the aforementioned intravitreal method, or repeated applications of topical drugs like eye drops. With the advent of these new transporter-facilitated drugs, we can expect to see our ocular treatments become heavily improved, as well as the chance for complications diminish.” Ultimately, our client’s outstanding findings have been implemented by other experts among his field. Additionally, our client has been invited to judge the work of his colleagues and other forerunners in his field, and he has served as a manuscript reviewer for several internationally circulated journals. In total, he has reviewed 17 articles thus far. With the extensive and thorough documentation that we provided, we exhibited the immeasurable value of our client’s contributions to the current state of pharmaceutical research and development. In demonstrating the extraordinary ability of our client and international acclaim for his research, we were able to prove that he has risen to the very top of his field of endeavor. We were met with success when his EB-1A petition was approved in 6 months and 4 days.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 47,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 47,000 in 2023.